Active Surveillance for Small Renal Mass: Indications, Imaging, and When to Intervene

Summary Active surveillance (AS) is a nephron-sparing strategy for small renal masses (SRMs, ≤4 cm) that balances the indolent natural history of most SRMs against the morbidity of intervention. This review consolidates SRM definition, epidemiology, and growth kinetics; outlines patient/tumor selection criteria and progression triggers; details diagnostic evaluation and structured follow-up protocols; and presents outcomes, challenges, and controversies. Finally, we discuss emerging molecular, radiomic, and artificial-intelligence tools to refine AS and conclude with a forward-looking perspective on precision surveillance.

Authors

Institutions

Publication Details

Journal
UroCancer Clinics of India .
Published
2024-10-01
DOI
https://doi.org/10.4103/ucci.ucci_12_25
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Active Surveillance for Small Renal Mass: Indications, Imaging, and When to Intervene

Ravinder Singh, Sanjai K. Addla
UroCancer Clinics of India .
Renal cell carcinoma treatment
article

Active Surveillance for Small Renal Mass: Indications, Imaging, and When to Intervene

Ravinder Singh, Sanjai K. Addla
article en

Abstract

Summary Active surveillance (AS) is a nephron-sparing strategy for small renal masses (SRMs, ≤4 cm) that balances the indolent natural history of most SRMs against the morbidity of intervention. This review consolidates SRM definition, epidemiology, and growth kinetics; outlines patient/tumor selection criteria and progression triggers; details diagnostic evaluation and structured follow-up protocols; and presents outcomes, challenges, and controversies. Finally, we discuss emerging molecular, radiomic, and artificial-intelligence tools to refine AS and conclude with a forward-looking perspective on precision surveillance.

UroCancer Clinics of India .Vol. 2(4)
Apollo Hospitals (IN), Apollo Hospitals (IN), Apollo Hospitals (IN)
Openalex Percentile: Top 54%
Renal cell carcinoma treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.